EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications

Paras Mani Giri iD, Anurag Banerjee, Arpita Ghosal, Buddhadev Layek iD

International Journal of Molecular Sciences · 03.04.2024 · 25 (7) · 3995

DOI: 10.3390/ijms25073995 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.04.2024. Verfasst von Paras Mani Giri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, ND 58105, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 121-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences (NIGMS) Center of Biomedical Research Excellence (COBRE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative disorders (NDs) have become increasingly common during the past three decades. Approximately 15% of the total population of the world is affected by some form of NDs, resulting in physical and cognitive disability. The most common NDs include Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease. Although NDs are caused by a complex interaction of genetic, environmental, and lifestyle variables, neuroinflammation is known to be associated with all NDs, often leading to permanent damage to neurons of the central nervous system. Furthermore, numerous emerging pieces of evidence have demonstrated that inflammation not only supports the progression of NDs but can also serve as an initiator. Hence, various medicines capable of preventing or reducing neuroinflammation have been investigated as ND treatments. While anti-inflammatory medicine has shown promising benefits in several preclinical models, clinical outcomes are often questionable. In this review, we discuss various NDs with their current treatment strategies, the role of neuroinflammation in the pathophysiology of NDs, and the use of anti-inflammatory agents as a potential therapeutic option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyotrophic Lateral SclerosisHumansNeuroinflammatory DiseasesInflammationCentral Nervous System

Stichwörter der Autor:innen

Alzheimer’s diseaseHuntington’s diseaseParkinson’s diseaseamyotrophic lateral sclerosisanti-inflammatory drugsneurodegenerative disorders

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, ND 58105, USA.

ORCID-Profile: Paras Mani Giri, Buddhadev Layek

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences (NIGMS) Center of Biomedical Research Excellence (COBRE)

Zitieren

APA

Giri, P. M., Banerjee, A., Ghosal, A., & Layek, B. (2024). Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications. International Journal of Molecular Sciences, 25(7), 3995. https://doi.org/10.3390/ijms25073995

Vancouver

Giri PM, Banerjee A, Ghosal A, Layek B. Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications. International Journal of Molecular Sciences. 2024;25(7):3995. doi:10.3390/ijms25073995

BibTeX
@article{Giri2024,
  author = {Giri, Paras Mani and Banerjee, Anurag and Ghosal, Arpita and Layek, Buddhadev},
  title = {Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {7},
  pages = {3995},
  doi = {10.3390/ijms25073995}
}
Kostenlos starten →